Latest / Stock Movers / Fresnillo Rises, Barclays Falls, Abivax Surges
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some stocks on the move
- 0:18Speaker 3: today in Europe. I'm Stephen Carroll and I'm joined by
- 0:20Speaker 3: Bloomberg's Breaking News editor Louise Louise. Good morning. Let's start
- 0:24Speaker 3: with the miners. Their names like Fresnelo are rallying. What's
- 0:27Speaker 3: behind us?
- 0:28Speaker 1: Indeed, ye, Fresnelo is leading the foot See one hundred
- 0:30Speaker 1: with its gains, and then also up there among the
- 0:33Speaker 1: top rises on the FOOTWEO hundred, you've got en Devor Mining,
- 0:36Speaker 1: on the foot Sea two fifty, you've got Hotshild Mining,
- 0:38Speaker 1: Pan African Resources, and essentially they're all rallying after gold
- 0:42Speaker 1: and silver have a hit record highs. Obviously, this is
- 0:45Speaker 1: on the back of you know, the US Justice Department
- 0:48Speaker 1: threatening the FED with cron indictment. There's independence concerns around that.
- 0:52Speaker 1: There's also protests in Iran, and so there's you know,
- 0:56Speaker 1: this this stronger demand for safer assets and this is
- 0:59Speaker 1: pushing precious metals up, and then with that the miners.
- 1:03Speaker 1: So then as I say, they're they're really leading the
- 1:06Speaker 1: gains across the indexes this morning in London.
- 1:09Speaker 3: Okay, so that's on Fresnillo and miners this morning. We're
- 1:13Speaker 3: also watching shares in Barclays though, falling after the President
- 1:16Speaker 3: Trump's comments about credit card rates.
- 1:19Speaker 1: Indeed, yeah, so on the other end of the spectrum,
- 1:21Speaker 1: we've got Barkleays the biggest loser on the foot see
- 1:23Speaker 1: hundred in London this morning. As you say, falling fell
- 1:26Speaker 1: as much as four point eight percent this morning on
- 1:29Speaker 1: the back of these Trump comments. These were said on Sunday,
- 1:32Speaker 1: essentially saying that credit card lenders would be in violation
- 1:35Speaker 1: of the law if they don't do what he says
- 1:38Speaker 1: or he suggests and cap interest rates at ten percent
- 1:41Speaker 1: for one year. So he set a January twentieth deadline
- 1:44Speaker 1: for compliance on that for these banks to comply on that.
- 1:48Speaker 1: It's not you know, his demand is not backed up
- 1:51Speaker 1: by legislation, So it's not totally clear how these banks
- 1:54Speaker 1: would be breaking the law if they didn't comply with
- 1:56Speaker 1: what Trump says. But obviously it's bringing the into the crosshairs,
- 2:01Speaker 1: and you know, comments like that from Trump obviously move
- 2:06Speaker 1: markets a lot mover stop prices a lot. So Barclays
- 2:10Speaker 1: is the British one that's kind of moving on the
- 2:12Speaker 1: back of that. It's very exposed. It's got a US
- 2:14Speaker 1: credit card business. It makes about a third of its
- 2:16Speaker 1: net revenue in the US. So shares being pulled down
- 2:21Speaker 1: into the red quite heavily on the back of those comments.
- 2:24Speaker 3: Okay, and a huge surge in shares in the French
- 2:27Speaker 3: biotech for an abbi vax what's going on.
- 2:30Speaker 1: Indeed, as much as thirty one percent they're gains this morning.
- 2:34Speaker 1: This is about speculation about a possible takeover. So it's
- 2:39Speaker 1: already kind of been viewed as an attractive acquisition asset.
- 2:42Speaker 1: Their shares have risen hugely over the past year, almost
- 2:47Speaker 1: two thousand percent, on the view that it would be
- 2:49Speaker 1: an attractive acquisition target. And this is partly based around
- 2:53Speaker 1: they're expecting clinical trial results this year for a key drug,
- 2:57Speaker 1: for an experimental drug for inflammatory bowders, and so because
- 3:01Speaker 1: of that, you know, there's analyst saying that you can't
- 3:04Speaker 1: ignore that this would be one of the most used
- 3:05Speaker 1: products in the next decade. Because of that, it's becoming
- 3:08Speaker 1: or expecting to become an attractive acquisition target. The latest
- 3:13Speaker 1: speculation being reported by French media is that Eli Lilly
- 3:16Speaker 1: is ready to make an offer and that's for fifteen
- 3:18Speaker 1: billion euros to buy it. The company hasn't confirmed this,
- 3:22Speaker 1: but that is what's being reported, and you know they've
- 3:26Speaker 1: they've declined to comment about that. But as I say,
- 3:29Speaker 1: it's being positioned as a takeover target. There's eyes on it.
- 3:32Speaker 1: Shares a surging on the back of this, so we'll
- 3:34Speaker 1: becoming a close eye for this potential big MNA deal.
- 3:39Speaker 2: The Stock Mover's report from Bloomberg Radio. Check back with
- 3:43Speaker 2: us throughout the day for the latest roundup of companies
- 3:45Speaker 2: making news on Wall Street and for the latest market
- 3:49Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:53Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:57Speaker 2: the Bloomberg Business app.